ストックスクリーナーアプリを入手
5.458
1.75%
0.018
前日終値:
$5.44
開ける：
$5.44
24時間の取引高:
7,114
Relative Volume:
0.05
時価総額：
$71.59M
収益：
$52.29M
当期純損益:
$-73.52M
株価収益率:
-8.2697
EPS:
-0.66
ネットキャッシュフロー:
$-100.45M
1週間 パフォーマンス:
+8.53%
1か月 パフォーマンス:
-32.17%
6か月 パフォーマンス:
+14.60%
1年 パフォーマンス:
-24.07%
1日の値動き範囲:
$5.38
$5.535
1週間の範囲:
$4.8601
$5.51
52週間の値動き範囲:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
名前
Precision Biosciences Inc
セクター
電話
919-314-5512
住所
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.40 | 130.95M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.04 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.30 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.71 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
895.21 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.28 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 開始されました | Guggenheim | Buy |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-06-09 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 再開されました | BTIG Research | Buy |
| 2020-04-03 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-05 | 開始されました | Stifel | Buy |
| 2020-02-25 | 開始されました | William Blair | Outperform |
| 2019-08-09 | 開始されました | BTIG Research | Buy |
| 2019-07-16 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-22 | 開始されました | Barclays | Overweight |
| 2019-04-22 | 開始されました | Goldman | Buy |
| 2019-04-22 | 開始されました | JP Morgan | Overweight |
| 2019-04-22 | 開始されました | Jefferies | Buy |
すべてを表示
Precision Biosciences Inc (DTIL) 最新ニュース
How Precision BioSciences Inc. stock compares to industry benchmarksJuly 2025 Levels & Daily Momentum Trading Reports - BỘ NỘI VỤ
Will Precision BioSciences Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn
United StatesMintz Advises On Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mondaq
H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Will Precision BioSciences Inc. stock return to pre crisis levelsLayoff News & Growth Focused Stock Reports - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIFed Meeting & Technical Confirmation Alerts - newser.com
How analysts rate Precision BioSciences Inc. stock todayMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Will Precision BioSciences Inc. stock outperform Dow Jones indexAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will Precision BioSciences Inc. (PBS0) stock beat revenue estimates2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mintz
Precision BioSciences (DTIL) Price Target Decreased by 10.55% to 33.15 - MSN
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Momentum Check & Daily Stock Trend Reports - newser.com
Is Precision BioSciences Inc. stock dividend yield sustainableWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Precision BioSciences Inc. (DTIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why pension funds invest in Precision BioSciences Inc. (PBS0) stock2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Precision BioSciences (Nasdaq: DTIL) to Present PBGENE-HBV Trial Data at Hep-DART 2025 - Stock Titan
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire
Is Precision BioSciences Inc. (PBS0) stock in buy zone after pullback - newser.com
Genome Editing Market Research Report 2025-2032Industry - openPR.com
How hedge fund analytics apply to Precision BioSciences Inc. stock2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Multi asset correlation models including Precision BioSciences Inc.July 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Can Precision BioSciences Inc. stock resist market sell offsJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economy2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Real time breakdown of Precision BioSciences Inc. stock performanceIndex Update & Accurate Entry/Exit Alerts - newser.com
Has Precision BioSciences Inc. found a price floorPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Precision Biosciences Inc (DTIL) 財務データ
収益
当期純利益
現金流量
EPS
Precision Biosciences Inc (DTIL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
0.22%
大文字化:
|
ボリューム (24 時間):